A microbiologist works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the Centers for Disease Control and Prevention in Atlanta on November 25, 2013. Antimicrobial resistance is likely to kill nearly 400,000 Canadians and cost the economy about $400 billion in gross domestic product over the next 30 years, warns a landmark new report. An expert panel cautions in “When Antibiotics Fail: The growing cost of antimicrobial resistance in Canada” that the percentage of bacterial infections that are resistant to the drugs used to treat them is likely to grow from 26 per cent in 2018 to 40 per cent by 2050. THE CANADIAN PRESS/AP, David Goldman

A microbiologist works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the Centers for Disease Control and Prevention in Atlanta on November 25, 2013. Antimicrobial resistance is likely to kill nearly 400,000 Canadians and cost the economy about $400 billion in gross domestic product over the next 30 years, warns a landmark new report. An expert panel cautions in “When Antibiotics Fail: The growing cost of antimicrobial resistance in Canada” that the percentage of bacterial infections that are resistant to the drugs used to treat them is likely to grow from 26 per cent in 2018 to 40 per cent by 2050. THE CANADIAN PRESS/AP, David Goldman

Report predicts drug resistance likely to kill 400,000 Canadians by 2050

This increase is expected to cost Canada 396,000 lives, $120 billion in hospital expenses

Superbugs are likely to kill nearly 400,000 Canadians and cost the economy about $400 billion in gross domestic product over the next 30 years, warns a landmark report.

An expert panel cautions in “When Antibiotics Fail: The growing cost of antimicrobial resistance in Canada” that the percentage of bacterial infections that are resistant to treatment is likely to grow from 26 per cent in 2018 to 40 per cent by 2050.

This increase is expected to cost Canada 396,000 lives, $120 billion in hospital expenses and $388 billion in gross domestic product over the next three decades.

“This is almost as big, if not bigger, than climate change in a sense because this is directly impacting people. The numbers are just staggering,” says Brett Finlay, a University of British Columbia microbiology professor who chaired the panel, in an interview. “It’s time to do something now.”

The Public Health Agency of Canada commissioned the report on the socio-economic impacts of antimicrobial resistance and the Council of Canadian Academies assembled the independent panel. The 268-page document released Tuesday represents the most comprehensive picture to date of the country’s resistance rate as well as its costs to the health system and economy.

Antimicrobial resistance occurs when micro-organisms, including bacteria, viruses and fungi, evolve to resist the drugs that would otherwise kill them. Unnecessary antimicrobial use in humans and agriculture exacerbates the problem and widespread international travel and trade help resistant bacteria spread across the globe.

The most common antimicrobials are antibiotics, which treat infections caused by bacteria. The report focuses on resistant bacteria but uses the broader term antimicrobial because surveillance data tend to be collected under this heading.

An investigation by The Canadian Press last year revealed Canada has been sluggish to act on the growing threat. At that time, the federal government did not know how many Canadians were dying of resistant infections and it had not produced a plan that lays out responsibilities for provinces and territories.

A pan-Canadian action plan has still not materialized, but the new report estimates an annual death toll in Canada. The panel used the current resistance rate of 26 per cent to calculate that resistant infections contributed to over 14,000 deaths in 2018, and of those, 5,400 were directly attributable to the infections — only slightly less than those caused by Alzheimer’s disease.

ALSO READ: Flu season off to a fairly average start in B.C.: report

The panel’s economists used a more cautious model to project the impacts than a well-known international report by British economist Jim O’Neill, which predicted up to 10 million global deaths annually by 2050.

The Canadian report’s findings on the economic and social toll of antimicrobial resistance are stark. Currently, the problem costs the national health-care system $1.4 billion a year and by 2050, that figure is projected to grow to $7.6 billion, the report says. The cost to GDP is expected to jump from $2 billion to up to $21 billion annually.

Resistant infections decrease quality of life while increasing isolation and stigma and the impact will be unequally distributed as some socio-economic groups are more at risk, the report adds. These groups include Indigenous, low-income and homeless people, as well as those who travel to developing countries where resistant microbes are more common.

“Discrimination may be targeted at those with resistant infections or deemed to be at risk of infection,” the report warns. “Canadian society may become less open and trusting, with people less likely to travel and more supportive of closing Canada’s borders to migration and tourists.”

Antimicrobial resistance has the potential to impact everyone, Finlay says.

“It’s going to change the world,” he says. “We all go to hospitals and we all get infections.”

The report notes that resistance could increase the risk and reduce the availability of routine medical procedures including kidney dialysis, joint replacement, chemotherapy and caesarean section. These procedures all carry a threat of infections for which antibiotics are commonly prescribed.

Limiting the impacts of antimicrobial resistance requires a “complete re-evaluation” of health care in Canada, the report concludes.

The panel states that Canada lacks an effective federal, provincial and territorial surveillance system of antimicrobial resistance and use, with little comprehensive data describing the number of resistant infections and their characteristics.

It also calls for improved stewardship involving careful use of antimicrobials to preserve their effectiveness, strict infection prevention and control through hand hygiene, equipment cleaning and research and innovation for new treatments.

The report notes it’s unlikely that new broad-spectrum antimicrobials will be discovered. None have been found in decades and there’s little profit incentive for pharmaceutical companies to invest in drugs that quickly cure patients. However, the panel calls for more flexible regulations and incentives to promote discovery of new antimicrobials that treat infections caused by specific bacteria.

Alternative therapies are also being developed to treat or prevent resistant infections, including vaccines and treatments using phages, which are viruses that attack bacteria, the report adds.

Canada should immediately invest $120 million in research and innovation and up to $150 million in stewardship, education and infection control, matched by the provinces and territories, says Dr. John Conly, a panel member and University of Calgary professor specializing in chronic diseases.

The government and public should “absolutely” be as concerned about antimicrobial resistance as they are about climate change, Conly says.

“It’s a slow-moving tsunami. Like a tidal wave, it’s out at sea but it’s going to land on us much sooner than climate change.”

ALSO READ: Don Cherry says he was fired, not sorry for ‘Coach’s Corner’ poppy rant

Laura Kane, The Canadian Press


Like us on Facebook and follow us on Twitter.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta’s chief medical officer of health Dr. Deena Hinshaw and Premier Jason Kenney say the province would look at adding additional COVID-19 measures in the coming weeks if the virus continues to spread. (Photo by Government of Alberta)
Walk-in COVID-19 vaccination clinic to open in Red Deer

Alberta adds 1,345 new cases of the virus

Public health restrictions on non-essential travel and vacation bookings are being increased in B.C. (B.C. government)
COVID-19: B.C. announces signage along Alberta border to discourage non-essential travel

B.C. extends COVID-19 indoor dining, group fitness ban until May 25

A vial of some of the first 500,000 of the two million AstraZeneca COVID-19 vaccine doses that Canada has secured through a deal with the Serum Institute of India in partnership with Verity Pharma at a facility in Milton, Ont., on Wednesday, March 3, 2021. THE CANADIAN PRESS/Carlos Osorio - POOL
Alberta begins rolling out AstraZeneca COVID vaccine for those aged 40 or older

There are more than 70 pharmacies offering AstraZeneca, including 26 offering walk-in appointments

A child writes in their school notebook during a home schooling session in Cremona, Alta., Monday, March 23, 2020, amid the worldwide COVID-19 pandemic. Thousands of students in Calgary will shift to online learning as of today in a bid to curb rising COVID-19 infection rates in the city. THE CANADIAN PRESS/Jeff McIntosh
Online classes begin for some Alberta students amid rising COVID-19 cases

Alberta currently has the highest rate of active COVID-19 cases in the country

In this image from NASA, NASA’s experimental Mars helicopter Ingenuity lands on the surface of Mars Monday, April 19, 2021. The little 4-pound helicopter rose from the dusty red surface into the thin Martian air Monday, achieving the first powered, controlled flight on another planet. (NASA via AP)
VIDEO: NASA’s Mars helicopter takes flight, 1st for another planet

The $85 million helicopter demo was considered high risk, yet high reward

sign
Alberta Biobord Corp. recently hosted a virtual open house from Stettler

The company plans to develop a fuel pellet and medium density fibre board (MDF) plant near the community

The Rogers logo is photographed in Toronto on Monday, September 30, 2019. THE CANADIAN PRESS/Tijana Martin
Rogers investigating after wireless customers complain of widespread outage

According to Down Detector, problems are being reported in most major Canadian cities

People are shown at a COVID-19 vaccination site in Montreal, Sunday, April 18, 2021, as the COVID-19 pandemic continues in Canada and around the world. THE CANADIAN PRESS/Graham Hughes
Nothing stopping provinces from offering AstraZeneca vaccine to all adults: Hajdu

Health Canada has licensed the AstraZeneca shot for use in people over the age of 18

Deputy Prime Minister and Minister of Finance Chrystia Freeland responds to a question during Question Period in the House of Commons Tuesday December 8, 2020 in Ottawa. The stage is set for arguably the most important federal budget in recent memory, as the Liberal government prepares to unveil its plan for Canada’s post-pandemic recovery even as a third wave of COVID-19 rages across the country. THE CANADIAN PRESS/Adrian Wyld
Election reticence expected to temper political battle over federal budget

Opposition parties have laid out their own demands in the weeks leading up to the budget

Each spring, the Okanagan Fest-of-Ale is held in Penticton. This year, as a result of the COVID-19 pandemic, the festival will not be held. However, beer is still available. How much do you know about this beverage? (pxfuel.com)
QUIZ: How much do you really know about beer?

Put your knowledge to the test with this short quiz

Pall Bearers carrying the coffin of the Duke of Edinburgh, followed by the Prince of Wales, left and Princess Anne, right, into St George’s Chapel for his funeral, at Windsor Castle, in Windsor, England, Saturday April 17, 2021. (Danny Lawson/Pool via AP)
Trudeau announces $200K donation to Duke of Edinburgh award as Prince Philip laid to rest

A tribute to the late prince’s ‘remarkable life and his selfless service,’ the Prime Minister said Saturday

Most Read